Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
4.370
-0.030 (-0.68%)
Dec 20, 2024, 4:00 PM EST - Market closed
Annovis Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 60 | 192 | 110 | 142 | 52 | - | |
| Market Cap Growth | 23.02% | 75.03% | -23.01% | 174.06% | - | - | |
| Enterprise Value | 48 | 186 | 78 | 95 | 43 | - | |
| Last Close Price | 4.37 | 18.70 | 13.43 | 17.58 | 7.54 | - | |
| PB Ratio | 8.22 | -24.76 | 3.87 | 3.20 | 6.89 | - | |
| P/TBV Ratio | 14.90 | - | 3.87 | 3.20 | 6.89 | - | |
| Debt / Equity Ratio | - | - | - | - | - | -0.33 | |
| Quick Ratio | 2.34 | 1.34 | 3.69 | 30.33 | 13.96 | 0.37 | |
| Current Ratio | 2.66 | 2.39 | 4.68 | 30.54 | 14.04 | 0.37 | |
| Return on Equity (ROE) | -596.70% | -546.40% | -69.57% | -55.68% | -180.82% | - | |
| Return on Assets (ROA) | -154.58% | -121.77% | -38.88% | -33.58% | -89.86% | -171.82% | |
| Return on Capital (ROIC) | -276.95% | -273.63% | -43.79% | -34.92% | -126.89% | - | |
| Earnings Yield | -67.90% | -29.29% | -23.10% | -10.17% | -10.51% | - | |
| FCF Yield | -38.10% | -20.83% | -15.79% | -6.41% | -7.64% | - | |
| Buyback Yield / Dilution | -28.48% | -10.55% | -7.03% | -20.88% | -2132.36% | -1.81% | |
| Total Shareholder Return | -28.48% | -10.55% | -7.03% | -20.88% | -2132.36% | -1.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.